Caris Life Sciences, Inc. (CAI)

Nasdaq · Healthcare · Biotechnology
$17.58-5.18%As of 2026-11-22 · USD
Last session low $17.27Last session high $18.42
52-week low $14.1952-week high $36.50
Market cap
$5.04B
Sector
Healthcare
P/E (TTM)
10.6x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)21.8In the oversold range (below 30)
MACD (12, 26, 9)-3.13Below its signal line (-1.97); histogram -1.16
Bollinger %B (20, 2)11%Inside the bands (14.91 to 39.04)
SMA 2026.98Price is 34.8% below
SMA 5028.87Price is 39.1% below
SMA 20021.55Price is 18.4% below
ATR (20)11.38% of priceAverage true range per day
52-week position15%In the lower part of the 14.19 to 36.50 range

About Caris Life Sciences, Inc.

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.

Latest fiscal yearEnded 2025-12-31: revenue of $812.03M and an operating margin of 5.6%.

More in Biotechnology